Univ Rouen Normandie, Inserm, Normandie Univ, CBG UMR 1245, Rouen, France.
Institute of Research and Innovation in Biomedicine (IRIB), Rouen, France.
Nat Commun. 2024 Sep 29;15(1):8430. doi: 10.1038/s41467-024-52654-2.
Subarachnoid hemorrhage (SAH) can be associated with neurological deficits and has profound consequences for mortality and morbidity. Cerebral vasospasm (CVS) and delayed cerebral ischemia affect neurological outcomes in SAH patients, but their mechanisms are not fully understood, and effective treatments are limited. Here, we report that urotensin II receptor UT plays a pivotal role in both early events and delayed mechanisms following SAH in male mice. Few days post-SAH, UT expression is triggered by blood or hemoglobin in the leptomeningeal compartment. UT contributes to perimeningeal glia limitans astrocyte reactivity, microvascular alterations and neuroinflammation independent of CNS-associated macrophages (CAMs). Later, CAM-dependent vascular inflammation and subsequent CVS develop, leading to cognitive dysfunction. In an SAH model using humanized UT/ male mice, we show that post-SAH CVS and behavioral deficits, mediated by UT through Gq/PLC/Ca signaling, are prevented by UT antagonists. These results highlight the potential of targeting UT pathways to reduce early meningeal response and delayed cerebral ischemia in SAH patients.
蛛网膜下腔出血(SAH)可导致神经功能缺损,并对死亡率和发病率产生深远影响。脑血管痉挛(CVS)和迟发性脑缺血影响 SAH 患者的神经预后,但它们的机制尚未完全阐明,有效的治疗方法也有限。在这里,我们报告在雄性小鼠中,尾加压素 II 受体 UT 在 SAH 后的早期事件和迟发性机制中发挥关键作用。SAH 后几天,UT 表达被软脑膜间隙中的血液或血红蛋白触发。UT 有助于脑膜胶质界限星形胶质细胞反应性、微血管改变和神经炎症,而与中枢神经系统相关的巨噬细胞(CAMs)无关。后来,CAM 依赖性血管炎症和随后的 CVS 发展导致认知功能障碍。在使用人源化 UT/雄性小鼠的 SAH 模型中,我们表明,通过 UT 介导的 Gq/PLC/Ca 信号通路,UT 拮抗剂可预防 SAH 后 CVS 和行为缺陷。这些结果强调了靶向 UT 途径以减少 SAH 患者早期脑膜反应和迟发性脑缺血的潜力。